DERMATOFIBROSARCOMA PROTUBERANS

DERMATOFIBROSARCOMA PROTUBERANS was reported 96 times

These drug classes are most commonly taken by patients reporting DERMATOFIBROSARCOMA PROTUBERANS:

# Drug Count
0 Tumor Necrosis Factor Blocker [EPC] 16
1 Nonsteroidal Anti-inflammatory Drug [EPC] 9
2 Corticosteroid [EPC] 8
3 Alkylating Drug [EPC] 7
4 Purine Antimetabolite [EPC] 7
5 Benzodiazepine [EPC] 6
6 Folate Analog Metabolic Inhibitor [EPC] 6
7 Integrin Receptor Antagonist [EPC] 6
8 Calcineurin Inhibitor Immunosuppressant [EPC] 5
9 Interleukin-23 Antagonist [EPC] 5
10 Mood Stabilizer [EPC] 4
11 GLP-1 Receptor Agonist [EPC] 3
12 Interleukin-12 Antagonist [EPC] 3
13 Interleukin-6 Receptor Antagonist [EPC] 3
14 Platelet Aggregation Inhibitor [EPC] 3
15 Angiotensin 2 Receptor Blocker [EPC] 2
16 Angiotensin Converting Enzyme Inhibitor [EPC] 2
17 Anti-epileptic Agent [EPC] 2
18 Antimycobacterial [EPC] 2
19 Atypical Antipsychotic [EPC] 2
20 HMG-CoA Reductase Inhibitor [EPC] 2
21 Histamine-2 Receptor Antagonist [EPC] 2
22 Interferon beta [EPC] 2
23 Kinase Inhibitor [EPC] 2
24 Platinum-based Drug [EPC] 2
25 Proton Pump Inhibitor [EPC] 2
26 Thalidomide Analog [EPC] 2
27 5-alpha Reductase Inhibitor [EPC] 1
28 Acetylcholine Release Inhibitor [EPC] 1
29 Aldosterone Antagonist [EPC] 1
30 HER2/neu Receptor Antagonist [EPC] 1
31 Interleukin-4 Receptor alpha Antagonist [EPC] 1
32 Janus Kinase Inhibitor [EPC] 1
33 Leptin Analog [EPC] 1
34 Loop Diuretic [EPC] 1
35 Microtubule Inhibitor [EPC] 1
36 Neuromuscular Blocker [EPC] 1
37 Provitamin D2 Compound [EPC] 1
38 Pyrimidine Synthesis Inhibitor [EPC] 1
39 Retinoid [EPC] 1
40 Serotonin Reuptake Inhibitor [EPC] 1
41 Thiazide Diuretic [EPC] 1
42 Topoisomerase Inhibitor [EPC] 1